Spruce Biosciences Inc — Cash Flow (NASDAQ:SPRB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 27.52 M35.88 M41.68 M33.27 M55.96 M 47.55 M Cash from investing activities 74 K79.17 M23.69 M55.78 M0 — Cash from financing activities 181.03 M643 K241 K49.14 M1.62 M 1.84 M Free cash flow 27.45 M35.78 M41.67 M33.27 M55.96 M 47.55 M

News

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences - Spruce Biosciences (NASDAQ:SPRB)

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Oppenheimer initiates coverage on Spruce Biosciences stock with Outperform rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Spruce Biosciences stock rating resumed at Buy by H.C. Wainwright

Leerink Partners upgrades Spruce Biosciences stock to Outperform

Citizens raises Spruce Biosciences stock price target to $259 on MPS IIIB therapy

Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy

Spruce Biosciences stock price target raised to $160 from $10 at Leerink

What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now?

Stock Market Mixed, But AMD, Nvidia, Taiwan Semi Lift AI; Tesla Launches Stripped-Down EVs: Weekly Review